IMPURITY-2;{1-[1-{3-[2-(7-CHLORO-QUINOLIN-2-YL)-VINYL]-PHENYL}-3-(2-ISOPROPENYL-PHENYL)
Compound with spectra: 1 NMR
![IMPURITY-2;{1-[1-{3-[2-(7-CHLORO-QUINOLIN-2-YL)-VINYL]-PHENYL}-3-(2-ISOPROPENYL-PHENYL)](/api/compound/8Hs3araoXVS.png?ph=true&h=300&w=458 "IMPURITY-2;{1-[1-{3-[2-(7-CHLORO-QUINOLIN-2-YL)-VINYL]-PHENYL}-3-(2-ISOPROPENYL-PHENYL)")
| SpectraBase Compound ID | 8Hs3araoXVS |
|---|---|
| InChI | InChI=1S/C35H34ClNO2S/c1-24(2)31-9-4-3-7-26(31)13-17-33(40-23-35(18-19-35)22-34(38)39)28-8-5-6-25(20-28)10-15-30-16-12-27-11-14-29(36)21-32(27)37-30/h3-12,14-16,20-21,33H,1,13,17-19,22-23H2,2H3,(H,38,39)/b15-10+/t33-/m0/s1 |
| InChIKey | LLGQICNFACCGPR-DNMUBJEDSA-N |
| Mol Weight | 568.2 g/mol |
| Molecular Formula | C35H34ClNO2S |
| Exact Mass | 567.199878 g/mol |
| Enantiomer InChIKey | LLGQICNFACCGPR-LDXVMNHOSA-N |
| Racemate InChIKey | LLGQICNFACCGPR-XNTDXEJSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
IMPURITY-4;1-[[[(1-R)-1-[3-[(1-E)-2-(2-QUINOLINYL)-ETHENYL]-PHENYL-3-[2-(1-HYDROXY-1-METHYLETHYL)-PHENYL]-PROPYL]-THIO]-
trans-1-ethyl-2-[2-(8-hydroxy-5-quinolinyl)vinyl]quinolinium chloride, hydrochloride, dihydrate
cis-1-ethyl-2-[2-(8-hydroxy-5-quinolinyl)vinyl]quinolinium chloride, hydrochloride
TMC-120-DERIVATIVE-1
Methyl 7-chloro-2-(p-tolyl)quinoline-4-carboxylate
9H-carbazole-2-acetamide, 6-chloro-alpha-methyl-N-(4-methylphenyl)-
2-cyclopropyl-N'-[(E)-(3,5-dibromo-2-hydroxyphenyl)methylidene]-4-quinolinecarbohydrazide
2-{(E)-2-[5-(2-nitrophenyl)-2-furyl]ethenyl}-8-quinolinol
2-chlorobenzyl 2-{(E)-2-[5-(4-nitrophenyl)-2-furyl]ethenyl}-8-quinolinyl ether
2'-METHOXY-6'',6''-DIMETHYL-CHROMENO-[2'',3'':4',3']-BETA-HYDROXY-CHALCONE
| Title | Journal or Book | Year |
|---|---|---|
| Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium | Journal of Pharmaceutical and Biomedical Analysis | 2008 |